A groundbreaking one-time gene therapy has the potential to liberate individuals suffering from α-thalassemia, a rare and debilitating blood disorder, from the necessity of lifelong blood transfusions. Image by kjpargeter…

Subscribe Now for Real-time Updates on the Latest Stories!
Isabella Cueto, a renowned expert in chronic diseases, particularly autoimmune conditions and diseases of the liver, kidneys, and lungs, provides…
Canada has recently lost its measles elimination status, a designation it had held since 1998, due to ongoing measles outbreaks…
An organization's competitive edge is defined by its AI adoption strategy. CIOs are tasked with managing the rapid deployment of…
Government-led cash transfer programs have been shown to drive significant improvements in health outcomes across low- and middle-income countries (LMICs),…
The Liver Meeting, hosted by the American Association for the Study of Liver Diseases, recently provided updates on the latest…
Adults who experience poverty-level family income—whether sustained or intermittent—over two decades spanning young to mid-adulthood face a significantly higher risk…
Canada has recently been stripped of its measles elimination status, a significant blow to the country's public health efforts. This…
The Food and Drug Administration has made a significant reversal of a decision dating back to 2003 regarding hormone therapy…
Sign in to your account